☆ 4.6 Article

Profiling of miRNAs and their interfering targets in peripheral blood mononuclear cells from patients with chronic myeloid leukaemia

FRONTIERS IN ONCOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Tissue-Specific microRNA Expression Profiling to Derive Novel Biomarkers for the Diagnosis and Subtyping of Small B-Cell Lymphomas

Susan Swee-Shan Hue et al.

Summary: It is challenging for pathologists to accurately diagnose small B-cell lymphomas due to overlapping morphological features and limitations of current ancillary testing. In this study, we identified and validated two sets of microRNA biomarkers that can distinguish small B-cell lymphomas from reactive lymphoid tissue and differentiate between the subtypes of these lymphomas. This study suggests that miRNA expression profiling may serve as a promising diagnostic tool for small B-cell lymphomas.

CANCERS (2023)

添加到收藏夹

Article Oncology

Molecular subtypes predict therapeutic responses and identifying and validating diagnostic signatures based on machine learning in chronic myeloid leukemia

Fang-Min Zhong et al.

Summary: In this study, the biological characteristics of CML were analyzed, and diagnostic markers were identified. Two molecular subtypes were defined, and four genes were found to be diagnostic markers for CML. Furthermore, different subtypes showed different sensitivities to treatment drugs, and the risk score model could be used for differential diagnosis of CML and other hematological malignancies.

CANCER CELL INTERNATIONAL (2023)

添加到收藏夹

Review Oncology

Advances in the application of Let-7 microRNAs in the diagnosis, treatment and prognosis of leukemia

Hao Chen et al.

Summary: The Let-7 family of miRNAs plays a crucial role in various biological processes and is associated with tumor occurrence and prognosis. Let-7 is not only a potential diagnostic and prognostic marker for leukemia, but also a potential therapeutic target.

ONCOLOGY LETTERS (2022)

添加到收藏夹

Article Medical Laboratory Technology

MiR-150 Expression in Chronic Myeloid Leukemia: Relation to Imatinib Response

Eman M. Habib et al.

Summary: The study found that miR-150 expression in patients with CML significantly increased at 14 and 90 days after imatinib treatment, and it had predictive efficacy for ETR.

LABORATORY MEDICINE (2022)

添加到收藏夹

Article Hematology

Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring

Elias Jabbour et al.

Summary: Chronic Myeloid Leukemia (CML) is a myeloproliferative neoplasm characterized by a genetic translocation and fusion gene. Tyrosine kinase inhibitors (TKIs) are the frontline therapy, but second-line options are available for patients who develop resistance. Stem cell transplantation and non-TKI agents are recommended for advanced disease and relapse patients.

AMERICAN JOURNAL OF HEMATOLOGY (2022)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Exaggerated false positives by popular differential expression methods when analyzing human population samples

Yumei Li et al.

Summary: During population-level RNA-seq studies, the actual false discovery rates of DESeq2 and edgeR sometimes exceed 20%, recommending the use of the Wilcoxon rank-sum test.

GENOME BIOLOGY (2022)

添加到收藏夹

Article Hematology

Role of c-Myc haploinsufficiency in the maintenance of HSCs in mice

Yue Sheng et al.

Summary: This study investigated the dosage effect of c-Myc on hematopoiesis and its role in the Wnt/beta-catenin pathway in HSC and bone marrow niche cells. The results demonstrated the critical role of Nr4a1, Nr4a2, and Jmjd3 as downstream targets of c-Myc in HSCs. Additionally, the study provided evidence of c-Myc-mediated Apc loss inducing IL6 secretion in endothelial cells and its impact on erythroid cell differentiation.

BLOOD (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

miRNome profiling of LSC-enriched CD34+CD38-CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool

Maria Sol Ruiz et al.

Summary: This study analyzed the miRNome of LSC and HSC-enriched fractions from CML patients, revealing a global decrease in microRNA levels and potential silencing of multiple non-coding RNAs. Despite the absence of BCR-ABL1 expression, an altered miRNome was observed in HSC. The findings suggest a potential role of microRNA in metabolic vulnerabilities in LSC and provide valuable data for future studies and therapeutic strategies.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Article Hematology

EBF1 and PAX5 control pro-B cell expansion via opposing regulation of the Myc gene

Rajesh Somasundaram et al.

Summary: The study reveals that EBF1 directly regulates the Myc gene and EBF1 and PAX5 have opposing roles in regulating Myc levels. Experimental results demonstrate that EBF1 and PAX5 interact with each other in pro-B cell expansion and play important roles in regulating the MYC gene.

BLOOD (2021)

添加到收藏夹

Article Cell Biology

Aberrantly reduced expression of miR-342-5p contributes to CCND1-associated chronic myeloid leukemia progression and imatinib resistance

Yi-Ying Wu et al.

Summary: The study identified miR-342-5p as downregulated in CML patients, which played a significant role in regulating cell proliferation and DNA double-strand breaks through targeting the CCND1 gene expression region, enhancing imatinib-induced apoptosis. The clinical database analysis further confirmed the association between miR-342-5p and predicted molecular responses in CML patients, suggesting its potential as a target for future treatment or prognostic evaluation.

CELL DEATH & DISEASE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Targeting miR-126 in inv(16) acute myeloid leukemia inhibits leukemia development and leukemia stem cell maintenance

Lianjun Zhang et al.

Summary: The study elucidates that aberrant expression of miR-126 in inv(16) AML is directly induced by the CBFB-MYH11 fusion gene, promoting AML development and maintaining leukemia stem cells. This highlights miR-126 as a therapeutic target for inv(16) AML patients.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Oncology

Tumor Suppressor miR-584-5p Inhibits Migration and Invasion in Smoking Related Non-Small Cell Lung Cancer Cells by Targeting YKT6

Saet Byeol Lee et al.

Summary: Cigarette smoke induces DNA methylation, which downregulates the expression of miR-584-5p in smoking-related lung carcinogenesis. MiR-584-5p suppresses migration and invasion in NSCLC cells by targeting YKT6, and its reduced expression is associated with cancer progression, suggesting it as a potential molecular biomarker for smoking-related NSCLC.

CANCERS (2021)

添加到收藏夹

Review Cell Biology

The many facets of miR-223 in cancer: Oncosuppressor, oncogenic driver, therapeutic target, and biomarker of response

Andrea Favero et al.

Summary: miR-223 has diverse functions in different cancer types, acting as either an oncogene or a tumor suppressor. Its expression may be associated with treatment response and prognosis in certain cancer types.

WILEY INTERDISCIPLINARY REVIEWS-RNA (2021)

添加到收藏夹

Article Oncology

Targeting Chronic Myeloid Leukemia Stem/Progenitor Cells Using Venetoclax-Loaded Immunoliposome

Mohammad Houshmand et al.

Summary: The study successfully targeted CML LSCs/progenitor cells by designing a liposome conjugated with Begelomab and loaded with venetoclax, leading to improved treatment outcomes. The system demonstrated the ability to eliminate CD26+ LSCs/progenitor cells while sparing CD26- cells. Treatment of patient samples with IL-VX significantly reduced the number of CD26+ cells.

CANCERS (2021)

添加到收藏夹

Article Oncology

CML derived exosomes promote tumor favorable functional performance in T cells

Nazli Jafarzadeh et al.

Summary: The study shows that K562-derived exosomes stimulate the immunosuppressive properties in human primary cord blood-derived T cells by affecting gene expression, cytokine secretion, and redox potential.

BMC CANCER (2021)

添加到收藏夹

Article Medicine, General & Internal

Circulating miR-146a expression predicts early treatment response to imatinib in adult chronic myeloid leukemia

Eman M. Habib et al.

Summary: This study aimed to investigate the prognostic role of circulating miR-146a in predicting early response to imatinib treatment in CML patients. It found that miR-146a levels at day 14 can predict treatment response, and patients with lower baseline Sokal scores and decreased BCR-ABL expression at day 90 were more likely to respond. The study suggests that miR-146a may serve as a potential biomarker for treatment response in CML patients.

JOURNAL OF INVESTIGATIVE MEDICINE (2021)

添加到收藏夹

Article Hematology

Myeloid cell-targeted miR-146a mimic inhibits NF-κB-driven inflammation and leukemia progression in vivo

Yu-Lin Su et al.

BLOOD (2020)

添加到收藏夹

Article Hematology

Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in Patients with Philadelphia Chromosome-Positive Advanced Myeloid Leukemias

Abhishek Maiti et al.

ACTA HAEMATOLOGICA (2020)

添加到收藏夹

Article Medicine, Research & Experimental

MicroRNA-145 promotes the apoptosis of leukemic stem cells and enhances drug-resistant K562/ADM cell sensitivity to adriamycin via the regulation of ABCE1

Zhijun Wuxiao et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2020)

添加到收藏夹

Article Cell Biology

Shikonin overcomes drug resistance and induces necroptosis by regulating the miR-92a-1-5p/MLKL axis in chronic myeloid leukemia

Xianbo Huang et al.

AGING-US (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

The NCATS BioPlanet - An Integrated Platform for Exploring the Universe of Cellular Signaling Pathways for Toxicology, Systems Biology, and Chemical Genomics

Ruili Huang et al.

FRONTIERS IN PHARMACOLOGY (2019)

添加到收藏夹

Article Multidisciplinary Sciences

MicroRNA signature refine response prediction in CML

Raquel Alves et al.

SCIENTIFIC REPORTS (2019)

添加到收藏夹

Review Hematology

Extracellular vesicles in the hematopoietic microenvironment

John T. Butler et al.

HAEMATOLOGICA (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Molecular transitions in early progenitors during human cord blood hematopoiesis

Shiwei Zheng et al.

MOLECULAR SYSTEMS BIOLOGY (2018)

添加到收藏夹

Review Hematology

Extracellular vesicles in the hematopoietic microenvironment

John T. Butler et al.

HAEMATOLOGICA (2018)

添加到收藏夹

Article Hematology

The Human Cell Atlas bone marrow single-cell interactive web portal

Stuart B. Hay et al.

EXPERIMENTAL HEMATOLOGY (2018)

添加到收藏夹

Article Biochemical Research Methods

Single sample scoring of molecular phenotypes

Momeneh Foroutan et al.

BMC BIOINFORMATICS (2018)

添加到收藏夹

Review Oncology

miRNAs in chronic myeloid leukemia: small molecules, essential function

Zofia Litwinska et al.

LEUKEMIA & LYMPHOMA (2017)

添加到收藏夹

Article Medicine, General & Internal

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

Andreas Hochhaus et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

添加到收藏夹

Review Pharmacology & Pharmacy

Regulation of multidrug resistance by microRNAs in anti-cancer therapy

Xin An et al.

ACTA PHARMACEUTICA SINICA B (2017)

添加到收藏夹

Review Biochemistry & Molecular Biology

The role of microenvironment and immunity in drug response in leukemia

Emyr Bakker et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)

添加到收藏夹

Article Cell Biology

Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells

Bing Z. Carter et al.

SCIENCE TRANSLATIONAL MEDICINE (2016)

添加到收藏夹

Article Hematology

Platelet Dysfunction in Patients with Chronic Myeloid Leukemia: Does Imatinib Mesylate Improve It?

Olga Meltem Akay et al.

TURKISH JOURNAL OF HEMATOLOGY (2016)

添加到收藏夹

Article Oncology

Restoration of miR-424 suppresses BCR-ABL activity and sensitizes CML cells to imatinib treatment

Oshrat Hershkovitz-Rokah et al.

CANCER LETTERS (2015)

添加到收藏夹

Article Chemistry, Medicinal

miRNAs as Biomarkers in Chronic Myelogenous Leukemia

Kasuen Kotagama et al.

DRUG DEVELOPMENT RESEARCH (2015)

添加到收藏夹

Article Biochemical Research Methods

circlize implements and enhances circular visualization in R

Zuguang Gu et al.

BIOINFORMATICS (2014)

添加到收藏夹

Article Biotechnology & Applied Microbiology

The malignancy suppression role of miR-23a by targeting the BCR/ABL oncogene in chromic myeloid leukemia

Z. Xishan et al.

CANCER GENE THERAPY (2014)

添加到收藏夹

Article Oncology

The BCL2 inhibitor ABT-199 significantly enhances imatinib-induced cell death in chronic myeloid leukemia progenitors

Tun Kiat Ko et al.

ONCOTARGET (2014)

添加到收藏夹

Article Oncology

Selective miRNA Expression Profile in Chronic Myeloid Leukemia K562 Cell-derived Exosomes

Dan-Qin Feng et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)

添加到收藏夹

Article Biochemistry & Molecular Biology

Stem cell gene expression programs influence clinical outcome in human leukemia

Kolja Eppert et al.

NATURE MEDICINE (2011)

添加到收藏夹

Article Oncology

The miR-17-92 microRNA Polycistron Regulates MLL Leukemia Stem Cell Potential by Modulating p21 Expression

Piu Wong et al.

CANCER RESEARCH (2010)

添加到收藏夹

Article Pharmacology & Pharmacy

Lyn Kinase-Dependent Regulation of miR181 and Myeloid Cell Leukemia-1 Expression: Implications for Drug Resistance in Myelogenous Leukemia

Eric I. Zimmerman et al.

MOLECULAR PHARMACOLOGY (2010)

添加到收藏夹

Article Cell Biology

MicroRNAs and cancer-new paradigms in molecular oncology

Massimo Negrini et al.

CURRENT OPINION IN CELL BIOLOGY (2009)

添加到收藏夹

Article Oncology

Molecular signature of CD34+ hematopoietic stem and progenitor cells of patients with CML in chronic phase

E. Diaz-Blanco et al.

LEUKEMIA (2007)

添加到收藏夹

Article Cell & Tissue Engineering

Transcriptional analysis of quiescent and proliferating CD34+human hemopoietic cells from normal and chronic myeloid leukemia sources

Susan M. Graham et al.

STEM CELLS (2007)

添加到收藏夹

Article Oncology

Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells

H. Gal et al.

LEUKEMIA (2006)

添加到收藏夹

Review Oncology

Oncomirs - microRNAs with a role in cancer

A Esquela-Kerscher et al.

NATURE REVIEWS CANCER (2006)

添加到收藏夹

Article Pathology

Detection of BCR/ABL fusion product in normoblasts in a case of chronic myelogenous leukemia

R McFarlane et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)

添加到收藏夹

Article Medicine, General & Internal

Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML

CHM Jamieson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

添加到收藏夹

Article Cell Biology

c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation

A Wilson et al.

GENES & DEVELOPMENT (2004)

添加到收藏夹

Review Hematology

The World Health Organization (WHO) classification of the myeloid neoplasms

JW Vardiman et al.

BLOOD (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.